Magnitude and time course of impaired primary haemostasis after stopping chronic low and medium dose aspirin in healthy volunteers

British Journal of Anaesthesia

Volumn 82, Issue 3, 1999, Pages 360-365

  Sonksen, J R ^b   Kong, K L ^a   Holder, R ^c  

^a CITY HOSPITAL   (United Kingdom)

^b RUSSELLS HALL HOSPITAL   (United Kingdom)

^c UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Blood, anticoagulants, aspirin; Blood, haemostasis; Pharmacology, aspirin

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT;

ADULT; ARTICLE; BLEEDING TIME; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG WITHDRAWAL; FEMALE; HEMOSTASIS; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; THROMBOCYTE FUNCTION; TIME;

EID: 0033052578     PISSN: 00070912     EISSN: None     Source Type: Journal    
DOI: 10.1093/bja/82.3.360     Document Type: Article

References (49)

1. Chronos NAF, Wilson DJ, Janes SL, Hutton RA, Buller NP, Goodall AH. Aspirin does not affect the flow cytometric detection of fibrinogen binding to, or release of α-granules or lysosomes from, human platelets. Clin Sci 1994; 87: 575-80
2. Packham MA. Role of platelets in thrombosis and haemostasis. Can J Physiol Pharmacol 1994; 72: 178-84
3. Barber A, Green D, Galluzzo T, Chung-hsin T. The bleeding time as a preoperative screening test. Am J Med 1985; 78: 761-4
4. Ferraris VA, Swanson E. Aspirin usage and perioperative blood loss in patients undergoing unexpected operations. Surg Gynecol Obstet 1983; 156: 439-42
5. Amrein PC, Ellman L, Harris WH. Aspirin-induced prolongation of the bleeding time and perioperative blood loss. JAMA 1981; 245: 1825-8
6. Meade TW, Howart DJ, Brennan PJ. Effects of low intensity antithrombotic regimes on the haemoglobin level. Thromb Haemost 1994; 71: 284-5
7. Juul-Moller S. Double-blind trial of aspirin in primary prevention of myocardial infarction in patients with stable chronic angina pectoris. Lancet 1992; 340: 1421-4
8. Lanas A, Sekar MC, Hirschowitz BI. Objective evidence of aspirin use in both ulcer and nonulcer upper and lower gastrointestinal bleeding. Gastroenterology 1992; 103: 862-9
9. Matthewson K, Pugh S, Northfield TC. Which peptic ulcer patients bleed? Gut 1988; 29: 70-4
10. Gazelle GS, Haaga JR, Rowland DY. Bleeding due to needle biopsy: effect of venopirin in an animal model and implications for humans. J Vasc Interv Radiol 1993; 4: 305-10
11. Horlocker TT, Wedel DJ, Offord KP. Does preoperative antiplatelet therapy increase the risk of hemorrhagic complications associated with regional anesthesia? Anesth Analg 1990; 70: 631-4
12. Lawrence C, Sakuntabhai A, Tiling-Grosse S. Effect of aspirin and nonsteroidal antiinflammatory drug therapy on bleeding complications in dermatologic patients. J Am Acad Dermatol 1994; 31: 988-92
13. Shiffman ML, Farrel MT, Yee YS. Risk of bleeding after endoscopic biopsy in patients taking aspirin or other NSAIDS. Gastrointest Endosc 1994; 40: 458-62
14. Giangrande PLF, Littlewood TJ. Medical problems in surgical patients. 5.5. Haematological problems. In: Morris PJ, Malt RA, eds. Oxford Textbook of Surgery. Oxford: Oxford University Press, 1994; 212-21
15. Calandruccio RA. Arthroplasty of the hip. In: Crenshaw AH, ed. Campbell's Operative Orthopaedics. St Louis: CV Mosby, 1987; 1213-501
16. Rarick MU, Feinstein DI. Haematological problems and complications. In: Apuzzo MLJ, ed. Brain Surgery: Complication Avoidance and Management Edinburgh: Churchill Livingstone, 1993; 145-54
17. CLASP (Collaborative Low-dose Aspirin Study in Pregnancy) Collaborative Group. CLASP: a randomised trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women. Lancet 1994; 343: 619-29
18. Antiplatelet Trialists' Collaboration. Collaborative overview of randomised trials of antiplatelet therapy - I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ 1994; 308: 81-106
19. Steering Committee of the Physicians' Health Study Research Group. Final report on the aspirin component of the ongoing Physicians' Health Study. N Engl J Med 1989; 321: 129-35
20. Deykin D, Janson P, McMahon L. Ethanol potentiation of aspirin-induced prolongation of the bleeding time. N Engl J Med 1982; 306: 852-4
21. Fiore LD, Brophy MT, Lopez A, Janson P, Deykin D. The bleeding time response to aspirin: identifying the hyperresponder. Am J Clin Pathol 1990; 94: 292-6
22. Trentalange MJ, Walts LF. A comparison of thromboelastogram and template bleeding time in the evaluation of platelet function after aspirin. J Clin Anesth 1991; 3: 377-81
23. Benzon HT, Brunner EA, Vaisrub N. Bleeding time and nerve blocks after aspirin. Reg Anesth 1983; 9: 86-9
24. Musgrave KA, Triplett DA, Daly CH, Schlossberg L, Bauaback AG. The Art and the Science of the Bleeding Time. New Jersey: International Technidyne Corporation, 1986
25. Mielke CH. Aspirin prolongation of the template bleeding time: Influence of venostasis and direction of incision. Blood 1982; 60: 1139-42
26. Bio/Data Corporation. Arachidonic Acid: For Use in Evaluation of Platelet Aggregation. Hatboro PA 19040: Bio/Data Corporation, 1981
27. Day JP, Lanas A, Rustagi P, Hirschowitz BI. Reversible prolonged skin bleeding time in acute gastrointestinal bleeding presumed due to NSAIDs. J Clin Gastroenterol 1996; 22: 96-103
28. Patrignani P, Filabozzi P, Patrono C. Selective cumulative inhibition of platelet thromboxane production by low-dose aspirin. J Clin Invest 1982; 69: 1366-72
29. Bochner F, Lloyd JV. Aspirin for myocardial infarction. Clinical pharmacokinetic considerations. Clin Pharmacokinet 1995; 28: 433-8
30. Bochner F, Williams DB, Morris PMA, Siebert DM, Lloyd JV. Pharmacokinetics of low-dose oral modified release, soluble and intravenous aspirin in man, and effects on platelet function. Eur J Clin Pharmacol 1988; 35: 287-94
31. Siebert DJ, Bochner F, Imhoff DM, et al. Aspirin kinetics and platelet aggregation in man. Clin Pharmacol Ther 1983; 33: 367-74
32. Pedersen AK, FitzGerald GA. Dose related kinetics of aspirin. N Engl J Med 1984; 311: 1206-11
33. van Pampus ECM, Huijgens PC, Zevenbergen A, Twaalfhoven H, van Kamp GJ, Langenhuijsen MMAC. Influence of aspirin on human megakaryocyte prostaglandin synthesis. Eur J Haematol 1993; 50: 264-8
34. Heyns AdP. Thrombopoiesis and platelet kinetics. In: Bloom AL, Forbes CD, Thomas DP, Toddenham EGD, eds. Haemostasis and Thrombosis. Edinburgh: Churchill Livingstone, 1994; 31-44
35. Mousa SA, Forsythe MS, Bozarth JM, Reilly TM. Effect of single oral dose of aspirin on human platelet functions and plasma plasminogen activator inhibitor-1. Cardiology 1993; 83: 367-73
36. Jimenez AH, Stubbs ME, Tofler GH, Winther K, Williams GH, Muller JE. Rapidity and duration of platelet suppression by enteric-coated aspirin in healthy young men. Am J Cardiol 1992; 69: 258-62
37. Eastham RD. Bleeding, Clotting and Transfusion. Clinical Haematology, 6th Edn. Bristol: John Wright and Sons, 1984; 239-399
38. Taylor ML, Misso NLA, Stewart GA, Thompson PJ. The effects of varying doses of aspirin on human platelet activation induced by PAF, collagen and arachidonic acid. Br J Clin Pharmacol 1992; 33: 25-31
39. Rao GH, White JG. Influence of various doses of aspirin (in vivo) on platelet arachidonic acid metabolism (ex vivo) and function. Prostaglandins Leukot Essent Fatty Acids 1994; 51: 63-7
40. Crawford N, Scrutton MC. Biochemistry of the blood platelet. In: Bloom AL, Forbes CD, Thomas DP, Toddenham EGD, eds. Haemostasis and Thrombosis. Edinburgh: Churchill Livingstone, 1994; 199-215
41. Thompson CB, Eaton KA, Princiotta SM, Rushin CA, Valeri CR. Size dependent platelet subpopulations: Relationship of platelet volume to ultrastructure, enzyme activity and function. Br J Haematol 1982; 50: 509-19
42. Mannucci PM, Sharp A. Platelet volume and shape in relation to aggregation and adhesion. Br J Haematol 1967; 13: 604-17
43. Packman MA, Kinlough-Rathbone RL, Mustard JF. Thromboxane A2 causes feedback amplification involving extensive thromboxane A2 formation on close contact of human platelets in media with a low concentration of ionized calcium. Blood 1987; 79: 647-51
44. Sutor A, Bowie E, Owen C jr. Effect of aspirin, sodium salicylate and acetaminophen on bleeding. Mayo Clin Proc 1971; 46: 178-81
45. Lanas A, Arroyo MT, Esteva F, Cornudella R, Garcia MA, Sainz R. Aspirin (ASA)-related upper Gl bleeders have an exaggerated bleeding time response due to ASA use. Gastroenterology 1994; 106: A121
46. de Swiet M, Redman C. Aspirin, extradural anaesthesia and the MRC collaborative low-dose aspirin study in pregnancy. Br J Anaesth 1992; 69: 109
47. Sibai B, Caritis S, Thom E, Shaw K, McNellis D, and the National Institute of Child Health and Human Development Maternal-Fetal Medicine Network. Low-dose aspirin in nulliparous women: Safety of continuous epidural block and correlation between bleeding time and maternal-neonatal bleeding complications. Am J Obstet Gynecol 1995; 172: 1553-7
48. Vandermeulen E, Van Aken H, Vermylen J. Anticoagulants and spinal-epidural anesthesia. Anesth Analg 1994; 79: 1165-77
49. Winocour PD. Platelet turnover in advanced diabetes. Eur J Clin Invest 1994; 24 (Suppl. 1): 34-7